Article Text

Download PDFPDF
The PTPN22 susceptibility risk variant is not associated with the rate of joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The first two authors contributed equally.

  • Funding The work of AHMvdH-vM is supported by The Netherlands Organisation for Health Research and Development and the Dutch Arthritis Association. The NARAC collection was supported by NIH grants NO1-AR-2-2263 and RO1 AR44422 to PKG.

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.